Show simple item record

dc.contributor.authorMolassiotis, Alexander
dc.contributor.authorMargulies, Anita
dc.contributor.authorFernandez-Ortega, Paz
dc.contributor.authorPud, Dorit
dc.contributor.authorPanteli, Vassiliki
dc.contributor.authorBruyns, Ingrid
dc.contributor.authorScott, Julia A
dc.contributor.authorGudmundsdottir, Gudbjorg
dc.contributor.authorBrowall, Maria
dc.contributor.authorMadsen, Elin
dc.contributor.authorOzden, Gulten
dc.contributor.authorMagri, Miriam
dc.contributor.authorSelvekerova, Sarka
dc.contributor.authorPlatin, Nurgun
dc.contributor.authorKearney, Nora
dc.contributor.authorPatiraki, Elisabeth
dc.date.accessioned2006-05-17T14:37:01Z
dc.date.available2006-05-17T14:37:01Z
dc.date.issued2005-05-01
dc.identifier.citationComplement Ther Clin Pract 2005, 11(2):105-10en
dc.identifier.issn1744-3881
dc.identifier.pmid15955292
dc.identifier.doi10.1016/j.ctcp.2004.12.005
dc.identifier.otherONC1212
dc.identifier.urihttp://hdl.handle.net/2336/2782
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Link fieldis
dc.description.abstractThis study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional well-being. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue.
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttp://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7MFN-4FYGC5H-1&_coverDate=05%2F31%2F2005&_alid=403421438&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=23263&_sort=d&view=c&_acct=C000058274&_version=1&_urlVersion=0&_userid=2631555&md5=c3b09a2375779ec5bced12c29fe05d12en
dc.subjectAdaptation, Psychologicalen
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectComplementary Therapiesen
dc.subjectCross-Sectional Studiesen
dc.subjectDecision Makingen
dc.subjectEducational Statusen
dc.subjectEuropeen
dc.subjectFemaleen
dc.subjectHealth Care Surveysen
dc.subjectHealth Knowledge, Attitudes, Practiceen
dc.subjectHematologic Neoplasmsen
dc.subjectHolistic Healthen
dc.subjectIncomeen
dc.subjectMiddle Ageden
dc.subjectMotivationen
dc.subjectOccupationen
dc.subjectPatient Acceptance of Health Careen
dc.subjectQuality of Lifeen
dc.subjectQuestionnairesen
dc.titleComplementary and alternative medicine use in patients with haematological malignancies in Europeen
dc.typeArticleen
dc.identifier.journalComplementary therapies in clinical practiceen
dc.format.digYES
html.description.abstractThis study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional well-being. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record